Vita Coco Company

Valuation Analysis

About the Company

Vita Coco Company en bref

Vita Coco Company (COCO) is currently trading at 57,17 € with a market capitalization of 3,3 Md €. The trailing P/E ratio stands at 36.43x, with a forward P/E of 28.18x. The 52-week range spans from 27,56 € to 74,41 €; the current price is 23.2% below the yearly high. Year-over-year revenue growth stands at +28.1%. The net profit margin stands at 15.5%.

💰 Dividende

Vita Coco Company currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

9 analystes évaluent Vita Coco Company (COCO) au consensus : Acheter. L'objectif de cours moyen est de 72,73 €, soit un potentiel de +27.22% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 58,96 € à 78,03 €.

Vita Coco Company : la thèse d'investissement en détail

Vita Coco Company (COCO) operates in the Consumer Defensive — specifically Beverages - Non-Alcoholic — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Top-line momentum is unusually strong with revenue expanding 28.1% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind. The combination of a 41.13% gross margin and 29.21% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Return on equity of 31.37% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard.

Le scénario baissier

Short interest sits at 11.77% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valorisation en contexte

The EV/EBITDA multiple of 25.77x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

À surveiller

• The forward P/E of 28.18x is meaningfully below the trailing 36.43x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 27.22% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (11.77%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Vita Coco Company?

Compare top-rated brokers — low fees, trusted providers, fully regulated.